Skip to content

Male Partner-assisted Contact Tracing for HIV and Tuberculosis in Malawi

Male Partner-assisted Contact Tracing for HIV and Tuberculosis in Malawi: a Feasibility and Acceptability Study, and Multi-arm Cluster-randomised Trial

Status
Terminated
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04285905
Acronym
mPATCH-TB
Enrollment
30
Registered
2020-02-26
Start date
2019-04-10
Completion date
2020-03-28
Last updated
2021-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

Tuberculosis

Brief summary

The overall aim of the mPATCH-TB Study is to identify potentially cost-effective, feasible and scalable interventions that could increase rates of completion of screening for tuberculosis and HIV among male partners of women attending primary health care in Blantyre, Malawi. Eligible women who consent to participate - and who have a primary male partner with cough at home -will be randomly allocated, by day of clinic attendance, into a standard of care group or one of up to four intervention groups. They will be asked to identify their primary male partner and will be offered interventions according to their allocated group. The primary outcome will compare the proportion of primary male partner that complete TB screening (defined as receipt of result of a sputum Xpert or smear result) within 14 days of recruitment in each intervention group compared to the enhanced standard of care group.

Interventions

OTHERAccess to Fast Track TB clinic

Male partner can attend clinic with dedicated services for men

OTHERInformation leaflet for male partner

Female participants will be provided with a letter asking their male partner to attend the clinic for tuberculosis screening

OTHERHome sputum collection

Female participants will be provided with sputum cups to take home and collect a sample of sputum from their male partner

OTHERHome HIV testing

Female participants will be provided with an oral HIV self-test kit to be given to their male partner with instructions for use

OTHERFinancial incentive

Female participants will be provided with a voucher for MKW5000 which can be redeemed when the male partner attends the clinic for TB testing

Sponsors

Malawi-Liverpool-Wellcome Trust Clinical Research Programme
CollaboratorOTHER
London School of Hygiene and Tropical Medicine
CollaboratorOTHER
University of Liverpool
CollaboratorOTHER
Liverpool School of Tropical Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for female participants * Female * Attends study health centre with an acute care episode * 18 years of age or older on the day of clinic attendance * Has a primary male partner living within their household * Reports that primary male partner has symptoms of pulmonary tuberculosis (cough) * Is resident within urban Blantyre Inclusion criteria for male partner participants * Male * Aged 18 years of age or older on the day of clinic attendance * Has cough * Is living with the female participant (defined as sleeping in the same dwelling on most nights during the previous 14 days)

Exclusion criteria

for primary male partner participants in trial (applied on the same day the female participant is recruited) * Currently taking treatment for tuberculosis * Has taken any treatment for tuberculosis in the 6-months prior to the female participant's clinic attendance * Is taking isoniazid preventive therapy * Plans to move out of Blantyre to live elsewhere in the following 2-months

Design outcomes

Primary

MeasureTime frameDescription
TB screeningWithin 14 days of recruitment of female participantThe proportion of male partners that complete TB screening

Secondary

MeasureTime frameDescription
TB case detectionWithin 14 days of recruitment of female participantThe proportion of male partners with either microbiologically-confirmed TB assessment, or taking TB treatment
AcceptabilityWithin 14 days of recruitment of female participantThe proportion of primary household male partners who report that they would be very likely or likely to recommend the interventions they received to their families or friends
Completion of HIV testingWithin 14 days of recruitment of female participantThe proportion of primary male household partners not receiving ART at baseline who report having been tested for HIV

Countries

Malawi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026